Your browser doesn't support javascript.
loading
A phase II study of ibrutinib and short-course fludarabine in previously untreated patients with chronic lymphocytic leukemia.
Pleyer, Christopher; Tian, Xin; Rampertaap, Shakuntala; Mu, Rui; Soto, Susan; Superata, Jeanine; Gaglione, Erika; Sun, Clare; Lotter, Jennifer; Stetler-Stevenson, Maryalice; Yuan, Constance M; Maric, Irina; Pittaluga, Stefania; Rosenzweig, Sergio; Fleisher, Thomas; Wiestner, Adrian; Ahn, Inhye E.
Afiliação
  • Pleyer C; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
  • Tian X; Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
  • Rampertaap S; Hematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.
  • Mu R; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
  • Soto S; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
  • Superata J; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
  • Gaglione E; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
  • Sun C; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
  • Lotter J; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
  • Stetler-Stevenson M; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Yuan CM; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Maric I; Hematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.
  • Pittaluga S; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Rosenzweig S; Hematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.
  • Fleisher T; Hematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.
  • Wiestner A; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
  • Ahn IE; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Am J Hematol ; 95(11): E310-E313, 2020 11.
Article em En | MEDLINE | ID: mdl-32808680
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article